"
Team:NYMU-Taipei/Project/Phosphate/Simulations/Phosphate
From 2008.igem.org
(Difference between revisions)
(→Phosphate Concentrations of normal and CKD patient) |
(→Phosphate Concentrations of normal and CKD patient) |
||
| Line 12: | Line 12: | ||
== Phosphate Concentrations of normal and CKD patient == | == Phosphate Concentrations of normal and CKD patient == | ||
* Normal adult (0.81 to 1.45 mmol/L) | * Normal adult (0.81 to 1.45 mmol/L) | ||
| - | * Chronic Kidney Disease patient (1.29 to 2.096 mmol/L) | + | * Chronic Kidney Disease (CDK) patient (1.29 to 2.096 mmol/L) |
* [http://www.merck.com/mmpe/sec12/ch156/ch156h.html Disorders of Phosphate Concentration by merck] | * [http://www.merck.com/mmpe/sec12/ch156/ch156h.html Disorders of Phosphate Concentration by merck] | ||
== Phosphate absorption == | == Phosphate absorption == | ||
assume 1mg/L therapeutic bacteria in the human intestine | assume 1mg/L therapeutic bacteria in the human intestine | ||
Revision as of 08:45, 30 October 2008
Transportation Efficiency of PIT and PST system
|
|
|
Phosphate Concentrations of normal and CKD patient
- Normal adult (0.81 to 1.45 mmol/L)
- Chronic Kidney Disease (CDK) patient (1.29 to 2.096 mmol/L)
- [http://www.merck.com/mmpe/sec12/ch156/ch156h.html Disorders of Phosphate Concentration by merck]
Phosphate absorption
assume 1mg/L therapeutic bacteria in the human intestine
